| Ophthalmic Partners Of Pennsylvania, Pc | |
|
100 Presidential Blvd, Suite 200, Bala Cynwyd, PA 19004-1108 | |
| (484) 434-2700 | |
| (610) 660-0419 |
| Full Name | Ophthalmic Partners Of Pennsylvania, Pc |
|---|---|
| Type | Facility |
| Speciality | Ophthalmology |
| Location | 100 Presidential Blvd, Bala Cynwyd, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912970666 | NPI | - | NPPES |
| 0010607290012 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OEG002793 (Pennsylvania) | Secondary |
| 207W00000X | Ophthalmology | MD052294L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ophthalmic Partners Of Pennsylvania, Pc 100 Presidential Blvd, Suite 200, Bala Cynwyd, PA 19004-1108 Ph: (484) 434-2700 | Ophthalmic Partners Of Pennsylvania, Pc 100 Presidential Blvd, Suite 200, Bala Cynwyd, PA 19004-1108 Ph: (484) 434-2700 |
News Archive
Psychiatric nurses have a one in ten chance of being physically injured by an aggressive patient over the course of a year and many more suffer emotional distress because of the verbal abuse they receive while working in these difficult and challenging environments.
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered how the most common genetic mutations in familial Parkinson's disease damage brain cells.
As part of a report released Wednesday, Obama administration officials cited evidence that hospitals are projected to save $5.7 billion in uncompensated care costs as previously uninsured patients gain coverage through the health law. The savings are most significant in states that expanded their Medicaid programs.
Antigen Discovery, Inc. today announced that it has received a Phase II Small Business Innovation and Research award from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health. The three-year award, totaling approximately $ 2.5 million, is a continuation of a Phase I SBIR grant to scan the Plasmodium falciparum proteome for protective antigens.
The UK announced Saturday they will remove the mercury preservative Thimerosal from their vaccines. The news comes days after an LA Times article reported that Aventis-Pasteur, a pharmaceutical giant, is pushing to keep the toxin in U.S. vaccines.
› Verified 7 days ago